Duration of Implantable Cardiac Monitoring and Detection of Atrial Fibrillation in Ischemic Stroke Patients: A Systematic Review and Meta-Analysis
- Author:
Georgios TSIVGOULIS
1
;
Aristeidis H KATSANOS
;
Martin KÖHRMANN
;
Valeria CASO
;
Fabienne PERREN
;
Lina PALAIODIMOU
;
Spyridon DEFTEREOS
;
Sotirios GIANNOPOULOS
;
John ELLUL
;
Christos KROGIAS
;
Dimitris MAVRIDIS
;
Sokratis TRIANTAFYLLOU
;
Anne W ALEXANDROV
;
Peter D SCHELLINGER
;
Andrei V ALEXANDROV
Author Information
- Publication Type:Meta-Analysis
- Keywords: Atrial fibrillation; Stroke; Monitoring; Meta-analysis
- MeSH: Atrial Fibrillation; Humans; Mass Screening; Stroke
- From:Journal of Stroke 2019;21(3):302-311
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND AND PURPOSE: Current guidelines do not provide firm directions on atrial fibrillation (AF) screening after ischemic stroke (IS). We sought to investigate the association of implantable cardiac monitoring (ICM) duration with the yield of AF detection in IS patients. METHODS: We included studies reporting AF detection rates by ICM in IS patients with negative initial AF screening. We excluded studies reporting prolonged cardiac monitoring with devices other than ICM, not providing AF detection rates or monitoring duration, and reporting overlapping data for the same population. The random-effects model was used for all pooled estimates and meta-regression analyses. RESULTS: We included 28 studies (4,531 patients, mean age 65 years). In meta-regression analyses, the proportion of AF detection by ICM was independently associated with monitoring duration (coefficient=0.015; 95% confidence interval [CI], 0.005 to 0.024) and mean patient age (coefficient=0.009; 95% CI, 0.003 to 0.015). No associations were detected with other patient characteristics, including IS subtype (cryptogenic vs. embolic stroke of undetermined source) or time from IS onset to CM implantation. In subgroup analyses, significant differences (P<0.001) in the AF detection rates were found for ICM duration (<6 months: 5% [95% CI, 3% to 6%]; ≥6 and ≤12 months: 21% [95% CI, 16% to 25%]; >12 and ≤24 months: 26% [95% CI, 22% to 31%]; >24 months: 34% [95% CI, 29% to 39%]). CONCLUSIONS: Extended duration of ICM monitoring and increased patient age are factors that substantially increase AF detection in IS patients with initial negative AF screening.
